BR112017002922A2 - ?processo para a produção em grande escala de dihidrocloreto de n-[4-(1-ciclobutil piperidin-4-iloxi) fenil]-2-(morfolin-4-il) acetamida? - Google Patents

?processo para a produção em grande escala de dihidrocloreto de n-[4-(1-ciclobutil piperidin-4-iloxi) fenil]-2-(morfolin-4-il) acetamida?

Info

Publication number
BR112017002922A2
BR112017002922A2 BR112017002922A BR112017002922A BR112017002922A2 BR 112017002922 A2 BR112017002922 A2 BR 112017002922A2 BR 112017002922 A BR112017002922 A BR 112017002922A BR 112017002922 A BR112017002922 A BR 112017002922A BR 112017002922 A2 BR112017002922 A2 BR 112017002922A2
Authority
BR
Brazil
Prior art keywords
morpholin
yloxy
phenyl
scale production
acetamide dihydrochloride
Prior art date
Application number
BR112017002922A
Other languages
English (en)
Other versions
BR112017002922B1 (pt
Inventor
Karbhari Shinde Anil
Narasimha Redd Gangadasari Pamuleti
Nirogi Ramakrishna
Kambhampati Ramasastri
Jasti Venkateswarlu
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of BR112017002922A2 publication Critical patent/BR112017002922A2/pt
Publication of BR112017002922B1 publication Critical patent/BR112017002922B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

a presente invenção se refere a um processo para a produção em grande escala de dihidrocloreto de n-[4-(1-ciclobutil piperidin-4-iloxi) fenil]-2-(morfolin-4-il) acetamida tendo a fórmula (i).
BR112017002922-7A 2014-08-16 2014-10-20 Processo para a produção de dihidrocloreto de n-[4-(1-ciclobutil piperidin-4-iloxi) fenil]-2- (morfolin-4-il) acetamida BR112017002922B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4010/CHE/2014 2014-08-16
IN4010CH2014 2014-08-16
PCT/IN2014/000666 WO2016027275A1 (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Publications (2)

Publication Number Publication Date
BR112017002922A2 true BR112017002922A2 (pt) 2017-12-05
BR112017002922B1 BR112017002922B1 (pt) 2023-01-03

Family

ID=52339255

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017002922-7A BR112017002922B1 (pt) 2014-08-16 2014-10-20 Processo para a produção de dihidrocloreto de n-[4-(1-ciclobutil piperidin-4-iloxi) fenil]-2- (morfolin-4-il) acetamida

Country Status (28)

Country Link
US (1) US9802896B2 (pt)
EP (1) EP3180334B1 (pt)
JP (1) JP6385580B2 (pt)
KR (1) KR101860487B1 (pt)
CN (1) CN106573925B (pt)
AP (1) AP2017009753A0 (pt)
AU (1) AU2014403999B2 (pt)
BR (1) BR112017002922B1 (pt)
CA (1) CA2957494C (pt)
CY (1) CY1121253T1 (pt)
DK (1) DK3180334T3 (pt)
EA (1) EA032823B1 (pt)
ES (1) ES2693378T3 (pt)
HK (1) HK1231472A1 (pt)
HR (1) HRP20181801T1 (pt)
HU (1) HUE041465T2 (pt)
IL (1) IL250412B (pt)
LT (1) LT3180334T (pt)
MX (1) MX364931B (pt)
NZ (1) NZ728915A (pt)
PL (1) PL3180334T3 (pt)
PT (1) PT3180334T (pt)
RS (1) RS57927B1 (pt)
SG (1) SG11201701104SA (pt)
SI (1) SI3180334T1 (pt)
TR (1) TR201816175T4 (pt)
WO (1) WO2016027275A1 (pt)
ZA (1) ZA201700936B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019229509A1 (en) * 2018-05-31 2019-12-05 Suven Life Sciences Limited Method of treatment with histamine-3 receptor inverse agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
CN103415510B (zh) * 2011-02-04 2016-01-13 庵原化学工业株式会社 氨苯基嘧啶基醇衍生物的制备方法及其合成中间体
BR112013021496B1 (pt) * 2011-02-23 2021-10-13 Suven Life Sciences Limited Composto, composição farmacêutica, uso da composição farmacêutica, processo para a preparação de um composto e uso do composto

Also Published As

Publication number Publication date
IL250412A0 (en) 2017-03-30
JP6385580B2 (ja) 2018-09-05
ES2693378T3 (es) 2018-12-11
WO2016027275A1 (en) 2016-02-25
CA2957494A1 (en) 2016-02-25
MX364931B (es) 2019-05-14
US20170260135A1 (en) 2017-09-14
EP3180334A1 (en) 2017-06-21
LT3180334T (lt) 2018-11-12
EA201790388A1 (ru) 2017-06-30
HRP20181801T1 (hr) 2018-12-28
PT3180334T (pt) 2018-11-16
JP2017525761A (ja) 2017-09-07
BR112017002922B1 (pt) 2023-01-03
CN106573925B (zh) 2020-04-10
ZA201700936B (en) 2019-07-31
MX2017002043A (es) 2017-05-04
DK3180334T3 (en) 2018-11-26
HUE041465T2 (hu) 2019-05-28
SI3180334T1 (sl) 2019-01-31
RS57927B1 (sr) 2019-01-31
HK1231472A1 (zh) 2017-12-22
AU2014403999A1 (en) 2017-02-23
KR101860487B1 (ko) 2018-05-23
AU2014403999B2 (en) 2017-12-14
IL250412B (en) 2019-11-28
PL3180334T3 (pl) 2019-03-29
AP2017009753A0 (en) 2017-02-28
KR20170036044A (ko) 2017-03-31
EP3180334B1 (en) 2018-09-26
SG11201701104SA (en) 2017-03-30
TR201816175T4 (tr) 2018-11-21
US9802896B2 (en) 2017-10-31
CN106573925A (zh) 2017-04-19
NZ728915A (en) 2018-01-26
CA2957494C (en) 2018-08-28
CY1121253T1 (el) 2020-05-29
EA032823B1 (ru) 2019-07-31

Similar Documents

Publication Publication Date Title
IL257390B (en) Salts of 1-((4-methoxymethyl)-4-(((s2,r1)-2-phenyl-cyclopropylamine)methyl)piperidine-1-yl)methyl)-cyclobutane-carboxylic acid as lsd1 inhibitors
BR112015019627A2 (pt) amidas heterocíclicas como inibidores de quinases
CU24411B1 (es) Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos
CR20150500A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril- aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
CL2015002309A1 (es) Proceso de fabricacion de vortioxetina.
BR112017028322A2 (pt) compostos, processo para a produção de compostos i, para a produção de compostos ii dos compostos iii e para a produção de compostos iii, compostos intermediários v e utilização dos compostos i
BR112017019850A2 (pt) ?processo melhorado para a preparação de apremilast?
BR112017005109A2 (pt) produto refratário com base em al2o3, composição de matérias-primas para a fabricação do produto, método para a fabricação de um produto refratário, produto refratário, e emprego do produto refratário
BR112017018993A2 (pt) Processo para preparar 3-cloro-2- vinilfenilassulfonatos
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
BR112018070345A2 (pt) processo para a preparação de derivados de 4-aminoindano e amidas de aminoindano relacionadas
BR112016027819A8 (pt) processo de preparação de derivados de tiazole
BR112017002922A2 (pt) ?processo para a produção em grande escala de dihidrocloreto de n-[4-(1-ciclobutil piperidin-4-iloxi) fenil]-2-(morfolin-4-il) acetamida?
DK3247699T3 (da) Proces til produktion of 2-[4-(cyclopropancarbonyl)phenyl]-2-methyl-propannitril
BR112016028700A2 (pt) processo para preparação de 3,5-bis(haloalquil)pirazoles via acilação de cetiminas
BR112017021336A2 (pt) método para produzir acilsulfamoilbenzamidas.
BR112015028751A2 (pt) processo para a preparação de derivados de 3,5-bis (fluoralquil)pirazol a partir de alfa,alfa-dihaloaminas
BR112018071748A2 (pt) processo para a preparação de compostos herbicidas
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
TH1701000768A (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
BR112018012696A2 (pt) processo aperfeiçoado para fabricação de crotonilaminopiridinas
MX2018009943A (es) Proceso para la fabricacion de derivados de 3-piperazin-1-il-propi lamina.
EA201991977A1 (ru) Новые кристаллические формы 1-(4-{[6-амино-5-(4-феноксифенил)пиримидин-4-иламино]метил}пиперидин-1-ил)пропенона
TH169412B (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
MX2016010549A (es) Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 413/12

Ipc: C07D 413/12 (2006.01), C07D 211/46 (2006.01), A61P

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/10/2014, OBSERVADAS AS CONDICOES LEGAIS